Vaxart (NASDAQ:VXRT) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) by 40 percent. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $4.93 million which beat the analyst consensus estimate of $850.00 thousand by 480.35 percent. This is a 134.79 percent increase over sales of $2.10 million the same period last year.